Literature DB >> 25199692

Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.

Ganesh P Subedi1, Quinlin M Hanson1, Adam W Barb2.   

Abstract

Immunoglobulin G1 (IgG1)-based therapies are widespread, and many function through interactions with low-affinity Fc γ receptors (FcγR). N-glycosylation of the IgG1 Fc domain is required for FcγR binding, though it is unclear why. Structures of the FcγR:Fc complex fail to explain this because the FcγR polypeptide does not bind the N-glycan. Here we identify a link between motion of the N-glycan and Fc:FcγRIIIa affinity that explains the N-glycan requirement. Fc F241 and F243 mutations decreased the N-glycan/polypeptide interaction and increased N-glycan mobility. The affinity of the Fc mutants for FcγRIIIa was directly proportional to the degree of glycan restriction (R(2) = 0.82). The IgG1 Fc K246F mutation stabilized the N-glycan and enhanced affinity for FcγRIIIa. Allosteric modulation of a protein/protein interaction represents a previously undescribed role for N-glycans in biology. Conserved features suggesting a similar N-glycan/aromatic interaction were also found in IgD, IgE, and IgM, but not IgA.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199692      PMCID: PMC4192013          DOI: 10.1016/j.str.2014.08.002

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  46 in total

1.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

Authors:  P Sondermann; R Huber; V Oosthuizen; U Jacob
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

2.  Contrasting IgG structures reveal extreme asymmetry and flexibility.

Authors:  Erica Ollmann Saphire; Robyn L Stanfield; M D Max Crispin; Paul W H I Parren; Pauline M Rudd; Raymond A Dwek; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  Plaque production by the polyoma virus.

Authors:  R DULBECCO; G FREEMAN
Journal:  Virology       Date:  1959-07       Impact factor: 3.616

4.  Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy.

Authors:  A Alavi; N Arden; T D Spector; J S Axford
Journal:  J Rheumatol       Date:  2000-06       Impact factor: 4.666

5.  Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.

Authors:  Philip J Reeves; Nico Callewaert; Roland Contreras; H Gobind Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

6.  Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha.

Authors:  S C Garman; B A Wurzburg; S S Tarchevskaya; J P Kinet; T S Jardetzky
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

7.  The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin.

Authors:  James N Arnold; Catherine M Radcliffe; Mark R Wormald; Louise Royle; David J Harvey; Max Crispin; Raymond A Dwek; Robert B Sim; Pauline M Rudd
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

8.  Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.

Authors:  J Lund; N Takahashi; J D Pound; M Goodall; R Jefferis
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

9.  Cloning, expression, purification, and characterization of the acid alpha-mannosidase from Trypanosoma cruzi.

Authors:  A S Vandersall-Nairn; R K Merkle; K O'Brien; T N Oeltmann; K W Moremen
Journal:  Glycobiology       Date:  1998-12       Impact factor: 4.313

10.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Authors:  S Krapp; Y Mimura; R Jefferis; R Huber; P Sondermann
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

View more
  38 in total

1.  From Rhesus macaque to human: structural evolutionary pathways for immunoglobulin G subclasses.

Authors:  William David Tolbert; Ganesh Prasad Subedi; Neelakshi Gohain; George Kenneth Lewis; Kashyap Rajesh Patel; Adam Wesley Barb; Marzena Pazgier
Journal:  MAbs       Date:  2019-04-02       Impact factor: 5.857

2.  Carbohydrate-Polypeptide Contacts in the Antibody Receptor CD16A Identified through Solution NMR Spectroscopy.

Authors:  Ganesh P Subedi; Daniel J Falconer; Adam W Barb
Journal:  Biochemistry       Date:  2017-06-16       Impact factor: 3.162

3.  CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

4.  The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  MAbs       Date:  2016-08-05       Impact factor: 5.857

Review 5.  A perspective on the structure and receptor binding properties of immunoglobulin G Fc.

Authors:  Quinlin M Hanson; Adam W Barb
Journal:  Biochemistry       Date:  2015-05-07       Impact factor: 3.162

6.  Structural characterization of the Man5 glycoform of human IgG3 Fc.

Authors:  Ishan S Shah; Scott Lovell; Nurjahan Mehzabeen; Kevin P Battaile; Thomas J Tolbert
Journal:  Mol Immunol       Date:  2017-10-12       Impact factor: 4.407

7.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

8.  The Structural Role of Antibody N-Glycosylation in Receptor Interactions.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  Structure       Date:  2015-07-23       Impact factor: 5.006

9.  Stabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic Sequon.

Authors:  Wentao Chen; Leopold Kong; Stephen Connelly; Julia M Dendle; Yu Liu; Ian A Wilson; Evan T Powers; Jeffery W Kelly
Journal:  ACS Chem Biol       Date:  2016-04-29       Impact factor: 5.100

10.  High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension.

Authors:  Ganesh P Subedi; Roy W Johnson; Heather A Moniz; Kelley W Moremen; Adam Barb
Journal:  J Vis Exp       Date:  2015-12-28       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.